Left Atrial Appendage Electrical Isolation Reduces Residual Patency After Device Closure in Patients With Persistent Atrial Fibrillation
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.046374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Peng-Cheng Yao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xinhua Hospital, School of Medicine Shanghai Jiao Tong University Shanghai China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Left Atrial Appendage Closure, Atrial Appendage, Catheter Ablation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Left atrial appendage (LAA) patency after catheter ablation and LAA closure (LAAC) is a key determinant of postprocedure stroke. The effect of LAA electrical isolation (LAAEI) on LAA patency after LAAC in patients with atrial fibrillation (AF) remains unknown. Our objective was to explore the effect of LAAEI on LAA patency after catheter ablation and LAAC in patients with AF.
Methods
Patients with persistent AF who underwent combined catheter ablation and LAAC were enrolled. LAA patency was detected by cardiac computed tomographic angiography at 3 months after the procedure.
Results
A total of 686 patients with persistent AF with 3‐month device surveillance by cardiac computed tomographic angiography were included initially. Propensity score matching analysis was conducted on the basis of clinical features, echocardiographic parameters and procedural characteristics, and 469 patients were matched, including 363 with non‐LAAEI and 106 with LAAEI. Patients in matched groups showed 53.7% complete closure (no patency). Of the 46.3% of cases with LAA patency, visible peridevice leak was seen in 72.8%, and 27.2% had patency without visible peridevice leak. Compared with the non‐LAAEI group, the LAAEI group had a lower rate of LAA patency (49.6% versus 34.9%; adjusted odds ratio, 0.69 [95% CI, 0.48–0.98]; P =0.040). LAAEI was protective against LAA patency with an odds ratio of 0.68, and the other predictor of contrast leak into the LAA was maximum diameter of LAA orifice (odds ratio, 1.04 [95% CI, 1.00–1.08]; P =0.046).
Conclusions
LAAEI is an effective strategy for reducing LAA patency in patients with persistent AF undergoing combined catheter ablation and LAAC. Registration URL: clinicaltrials.gov ; Unique Identifier: NCT03788941.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Xinhua Hospital, School of Medicine Shanghai Jiao Tong University Shanghai China.
ORCID-Profile: Peng-Cheng Yao, Mu Chen, Qun-Shan Wang, Mei Yang, Rui Zhang, Peng-Pai Zhang, Wei Li, Yan Zhao, Xiao-Ming Lian, Qian Wang, Xing-Xing Cai, Jian Sun, Yi-Gang Li
Zitieren
APA
Yao, P. C., Chen, M., Wang, Q. S., Yang, M., Zhang, R., Zhang, P. P., Li, W., Zhao, Y., Lian, X. M., Wang, Q., Fei, Y. D., Wei, Z. X., Yang, X. M., Cai, X. X., Sun, J., & Li, Y. G. (2026). Left Atrial Appendage Electrical Isolation Reduces Residual Patency After Device Closure in Patients With Persistent Atrial Fibrillation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.046374
Vancouver
Yao PC, Chen M, Wang QS, Yang M, Zhang R, Zhang PP, et al. Left Atrial Appendage Electrical Isolation Reduces Residual Patency After Device Closure in Patients With Persistent Atrial Fibrillation. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.046374
BibTeX
@article{Yao2026,
author = {Yao, Peng-Cheng and Chen, Mu and Wang, Qun-Shan and Yang, Mei and Zhang, Rui and Zhang, Peng-Pai and Li, Wei and Zhao, Yan and Lian, Xiao-Ming and Wang, Qian and Fei, Yu-Dong and Wei, Zhi-Xing and Yang, Xiao-Min and Cai, Xing-Xing and Sun, Jian and Li, Yi-Gang},
title = {Left Atrial Appendage Electrical Isolation Reduces Residual Patency After Device Closure in Patients With Persistent Atrial Fibrillation},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.046374}
}
EUVIMED